# Azadirachtin **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/azadirachtin **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-23 **Evidence Score:** 2 / 10 **Category:** Compound **Also Known As:** Azadirachta indica A. Juss., Neem limonoid, Margosa extract, Nimba, Indian lilac compound, Tetranortriterpenoid, Neem bioactive ## Overview Azadirachtin is a tetranortriterpenoid limonoid compound derived from neem seeds that demonstrates significant glycemic control properties. Clinical studies show it improves [insulin sensitivity](/ingredients/condition/weight-management) by modulating glucose metabolism pathways and reducing insulin resistance markers. ## Health Benefits • Glycemic control: 12-week RCT showed dose-dependent improvements with 57.4% reduction in HOMA-IR at 500mg BID of neem extract (moderate evidence) • [Insulin sensitivity](/ingredients/condition/weight-management): Clinical trial demonstrated significant improvements in insulin resistance markers in type 2 diabetes patients (moderate evidence) • [Endothelial function](/ingredients/condition/heart-health): Significant reduction in %RI (p≤0.0001) shown in diabetic patients taking standardized neem extract (moderate evidence) • Pancreatic cell protection: In vitro studies show protection against [oxidative stress](/ingredients/condition/antioxidant) and apoptosis in β-cells via AMPK/mTOR pathway (preliminary evidence) • Anti-parasitic activity: Inhibits Plasmodium development with IC50 of 12.4 μg/ml (preliminary evidence) ## Mechanism of Action Azadirachtin enhances glucose uptake by upregulating GLUT4 transporters and activating AMP-activated protein kinase (AMPK) pathways. The compound inhibits α-glucosidase and α-amylase enzymes, reducing postprandial glucose spikes. It also modulates insulin receptor signaling cascades, improving cellular glucose utilization and reducing hepatic glucose output. ## Clinical Summary A 12-week randomized controlled trial demonstrated dose-dependent glycemic improvements with neem extract containing azadirachtin. Participants receiving 500mg twice daily showed a 57.4% reduction in HOMA-IR (Homeostatic Model Assessment for Insulin Resistance). Clinical trials in type 2 diabetes patients revealed significant improvements in fasting glucose and [insulin sensitivity](/ingredients/condition/weight-management) markers. The evidence quality is moderate, with studies primarily conducted in diabetic populations. ## Nutritional Profile Azadirachtin is a highly oxygenated tetranortriterpenoid limonoid compound (molecular formula C35H44O16, molecular weight 720.7 g/mol) isolated primarily from neem (Azadirachta indica) seeds and leaves. It is not a macronutrient or micronutrient source itself but rather a concentrated bioactive secondary metabolite. Seed kernels from which it is extracted typically contain azadirachtin at concentrations of 0.2–0.8% dry weight (2,000–8,000 ppm), with high-quality cold-pressed neem seed oil containing approximately 300–2,500 ppm. Azadirachtin exists as multiple structural analogs: Azadirachtin A (most abundant, ~90% of total azadirachtins), Azadirachtin B (~7%), and trace amounts of variants C through K. The compound belongs to the limonoid class of tetranortriterpenoids and contains multiple functional groups including an enol ether, hemiacetal, tetrahydrofuranic ring, and tiglate ester moieties. Bioavailability is notably limited due to poor aqueous solubility (~0.5 mg/mL), rapid photodegradation (half-life of ~1 hour in direct sunlight), and thermal instability above 40°C. Oral bioavailability in mammalian systems is estimated to be low (<10%) due to first-pass [metabolism](/ingredients/condition/weight-management) and molecular complexity. The compound is typically accompanied in whole neem extracts by related limonoids including nimbin (~0.04% kernel dry weight), nimbidin (~2% kernel dry weight), salannin (~0.1% kernel dry weight), and gedunin (~0.07% kernel dry weight), which may contribute synergistic bioactivity. No significant vitamin, mineral, fiber, or protein content is attributable to azadirachtin itself as an isolated compound. ## Dosage & Preparation Clinically studied dosages are for neem extracts standardized to azadirachtin content: 125mg, 250mg, or 500mg twice daily, with 500mg BID showing superior outcomes for glycemic control over 12 weeks. No human dosage data exists for pure azadirachtin; animal studies use 25μM or equivalent to 100mg/kg neem azadirachtin. Consult a healthcare provider before starting any new supplement. ## Safety & Drug Interactions Azadirachtin is generally well-tolerated at therapeutic doses, with mild gastrointestinal upset reported in some users. It may potentiate hypoglycemic effects of diabetes medications, requiring [blood glucose](/ingredients/condition/weight-management) monitoring and potential dose adjustments. Pregnancy and lactation safety data is insufficient, warranting avoidance during these periods. Individuals with autoimmune conditions should exercise caution due to potential [immune system](/ingredients/condition/immune-support) modulation. ## Scientific Research Human clinical evidence is limited to neem extracts containing azadirachtin rather than isolated compounds. A key 12-week randomized, double-blind, placebo-controlled trial (CTRI/2018/12/016666) with 80 type 2 diabetes patients showed significant glycemic improvements at 500mg BID. Preclinical studies dominate the research, including pancreatic cell protection mechanisms (PMID: 34944759). ## Historical & Cultural Context Azadirachtin-rich neem has been used for centuries in Ayurvedic medicine for [antimicrobial](/ingredients/condition/immune-support), antiparasitic, [anti-inflammatory](/ingredients/condition/inflammation), and antidiabetic purposes, including treatment of skin disorders and fever. Historical texts document its dual role as both a natural pesticide and therapeutic agent across traditional Asian medical systems. ## Synergistic Combinations Chromium picolinate, Alpha-lipoic acid, Cinnamon extract, Bitter melon, Gymnema sylvestre ## Frequently Asked Questions ### What is the effective dosage of azadirachtin for diabetes? Clinical studies used 500mg twice daily of neem extract standardized for azadirachtin content. This dosage showed optimal glycemic benefits with a 57.4% reduction in insulin resistance markers over 12 weeks. ### How long does azadirachtin take to improve blood sugar? Significant improvements in insulin sensitivity markers appear within 4-6 weeks of consistent use. Maximum glycemic benefits were observed at 12 weeks in clinical trials, suggesting progressive metabolic improvements over time. ### Can azadirachtin replace diabetes medication? Azadirachtin should not replace prescribed diabetes medications without medical supervision. It works as an adjunctive therapy to enhance insulin sensitivity and may allow for medication dose reductions under physician guidance. ### What are the side effects of azadirachtin supplements? Common side effects include mild nausea, stomach upset, and occasional diarrhea, particularly at higher doses. These effects are typically transient and resolve with continued use or dose adjustment. ### Is azadirachtin safe to take with metformin? Azadirachtin may enhance metformin's glucose-lowering effects, potentially increasing hypoglycemia risk. Regular blood glucose monitoring is essential, and metformin dosage may require adjustment under medical supervision when combining these compounds. ### What does the research show about azadirachtin's effectiveness for blood sugar control? Clinical evidence demonstrates moderate support for azadirachtin's glycemic benefits, with a 12-week randomized controlled trial showing a 57.4% reduction in HOMA-IR (a marker of insulin resistance) at 500mg twice daily of neem extract. Multiple trials have documented significant improvements in insulin sensitivity and endothelial function in type 2 diabetes patients, though the overall evidence base is still developing. Most positive findings come from neem extracts standardized for azadirachtin content rather than isolated azadirachtin alone. ### Who are the best candidates for azadirachtin supplementation? Azadirachtin supplementation may be most beneficial for adults with type 2 diabetes or prediabetes who are seeking complementary support for insulin sensitivity and blood sugar management. Those with documented insulin resistance or elevated HOMA-IR scores, as measured in clinical trials, represent the primary population showing measurable benefits. Individuals looking to support endothelial function alongside glycemic control may also benefit, though supplementation should always complement rather than replace medical diabetes management. ### How does azadirachtin affect insulin sensitivity compared to other natural compounds? Azadirachtin's mechanism involves dose-dependent improvements in HOMA-IR and insulin resistance markers, with documented effects on endothelial function (showing significant reduction in vascular resistance markers). While comparative clinical trials directly pitting azadirachtin against other botanicals for diabetes support are limited, its dual action on both insulin signaling and vascular health distinguishes it from single-mechanism compounds. The moderate evidence base suggests azadirachtin may work synergistically with lifestyle interventions but requires direct head-to-head studies for definitive comparison with alternatives like berberine or alpha-lipoic acid. --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*